Academic partner
of Lymphoma
Clinical Research


LYSARC, since its creation (first as GELARC) has promoted and conducted numerous phase 1, 2, 3 and 4 clinical trials in the lymphoma field.

This has allowed the registration of new treatments and/or indications by the industrial owners of these products and an important scientific production by LYSA and its academic partners. Altogether, this has contributed to relevant progress in the medical management of several lymphoma types.
LYSARC collaborates at the international level with most of the companies and cooperative groups active in the lymphoma field.